Vimarsana
Biggest News Aggregation in the World

Molecular Classification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Classification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Classification Today - Breaking & Trending Today

St. Jude research highlighted at annual meeting of the American Society of Clinical Oncology - Vimarsana News

St. Jude research highlighted at annual meeting of the American Society of Clinical Oncology

/PRNewswire/ -- Professionals from St. Jude Children's Research Hospital will share original research and expertise at the American Society of Clinical...

St. Jude research highlighted at annual meeting of the American Society of Clinical Oncology - Vimarsana News

St. Jude research highlighted at annual meeting of the American Society of Clinical Oncology

/PRNewswire/ -- Professionals from St. Jude Children's Research Hospital will share original research and expertise at the American Society of Clinical...

Chinook Therapeutics Announces Upcoming Data Presentations - Vimarsana News

Chinook Therapeutics Announces Upcoming Data Presentations

Data on atrasentan to be presented in an oral presentation from the IgA nephropathy (IgAN) patient cohort of the phase 2 AFFINITY basket trialUpdated data...

Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call at the 59th European Renal Association (ERA) Congress - Vimarsana News

Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call at the 59th European Renal Association (ERA) Congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021 - Vimarsana News

Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021

Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021 - BT7480 to be presented in a “New Drugs on the Horizon” session; on-track to enter the clinic in 2H’21 CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle®) technology, today announced that for the first time, preclinical work describing the discovery of BT7480, a novel Nectin-4/CD137 tumor-targeted immune cell agonis...